
|Articles|March 1, 2001
The American Journal of Managed Care
- March 2001
- Volume 7
- Issue 3
Renal Effects of Angiotensin-Converting Enzyme Inhibitors That Result in Cost Savings and Improved Patient Outcomes
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
Immune Checkpoint Inhibitors Safe to Use for NSCLC in Patients With HIV
3
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
4
Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes
5















































